Neuralstem to Participate at Upcoming Investor Conferences
Mar 12, 2018 11:00 am UTC| Business
GERMANTOWN, Md., March 12, 2018 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that members of the management team will participate...
Humanigen Appoints Robert Savage to Board of Directors
Mar 12, 2018 11:00 am UTC| Business
BRISBANE, Calif., March 12, 2018 -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments,...
Mar 12, 2018 11:00 am UTC| Business
Initiates Financial Guidance for Full Year 2018Management to Host Conference Call at 8:00 AM ET today WAYNE, Pa., March 12, 2018 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical...
Art Gun Acquires DTG2Go Business
Mar 12, 2018 11:00 am UTC| Business
GREENVILLE, S.C., March 12, 2018 -- Delta Apparel, Inc. (NYSE American:DLA), a leading provider of basic and branded apparel, headwear and related accessories, today announced that Art Gun, LLC, its wholly-owned...
Mar 12, 2018 11:00 am UTC| Business
WASHINGTON, March 12, 2018 -- Geeks Without Frontiers (GEEKS) is delighted to announce strong support from the satellite and connectivity communities for its Community Connect initiative, designed to drive and inspire a...
Mar 12, 2018 11:00 am UTC| Business
SPOKANE, Wash., March 12, 2018 -- via OTC PR WIRE -- ("REGI" or "RGUS" or "the Company") The Board of Directors, Regi U.S., Inc. and its wholly owned subsidiary, RadMax Technologies, Inc., (USOTC:RGUS) announce that a...
Mar 12, 2018 11:00 am UTC| Business
Interim Analysis for Phase 3 HONOR study of Tonmya® (Cyclobenzaprine HCl Sublingual Tablets) inMilitary-Related PTSD Expected in Third Quarter of 2018; Topline Results Expected in Fourth Quarter of 2018 NEW YORK, March ...